The Clinical Research Unit at The Neuro — one of the largest neurological trial centres in Canada — has been at the forefront of cutting-edge therapies for 40 years. Today, the Unit’s efforts to advance treatments are focussed on novel therapeutics which are poised to revolutionize neurological care.
This day-long event will bring together international leaders developing the latest generation of treatments. The symposium is designed for scientists, health professionals and stakeholders from academia and industry involved in the development of novel therapeutics for rare diseases and offers a unique opportunity to connect with international researchers.
The symposium is a satellite of the annual meeting of the American Society of Human Genetics, and takes place the day before the start of ASHG proceedings.
EVENT INFORMATION
Date: Monday, October 19, 2026
Sessions: 9am to 4:30pm
Networking cocktail: 4:30pm to 6pm
Location: Le Centre Sheraton
1201 boul. René-Lévesque Ouest
Montréal, Québec, H3B 2L7
Métro: Bonaventure
Fyodor Urnov
University of California, Berkeley
We are excited to announce Fyodor Urnov as our keynote speaker. Urnov is a professor of molecular therapeutics at the University of California, Berkeley and director for therapeutic R&D of its Innovative Genomics Institute (IGI).
A key focus of Urnov’s work has been expanding access to CRISPR therapies for genetic disease. He directs the Danaher-IGI Beacon for CRISPR Cures – an academia-industry partnership developing and advancing to the clinic CRISPR-based platform approaches to treat severe Mendelian diseases of the immune system. He also directs the newly established CZI-IGI Center for Pediatric CRISPR Cures that aims to expand the “CRISPR on-demand” approach exemplified in that effort to multiple additional pediatric patients with severe genetic diseases.
PRELIMINARY PROGRAM
MEET OUR SPEAKERS
SUBMIT AN ABSTRACT
GOLD SPONSORS
BRONZE SPONSORS
